A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate by Aline R. M. Lobba, Aline R. M. Lobba, Miryam Paola Alvarez-Flores, Miryam Paola Alvarez-Flores, Melissa Regina Fessel, Melissa Regina Fessel, Marcus Vinicius Buri, Marcus Vinicius Buri, Douglas S. Oliveira, Douglas S. Oliveira, Douglas S. Oliveira, Renata N. Gomes, Renata N. Gomes, Priscila S. Cunegundes, Priscila S. Cunegundes, Priscila S. Cunegundes, Carlos DeOcesano-Pereira, Carlos DeOcesano-Pereira, Victor D. Cinel, Victor D. Cinel, Victor D. Cinel, Ana M. Chudzinski-Tavassi, Ana M. Chudzinski-Tavassi, Ana M. Chudzinski-Tavassi

Get full text

Dynein function and protein clearance changes in tumor cells induced by a Kunitz-type molecule, Amblyomin-X. by Mario T F Pacheco, Carolina M Berra, Kátia L P Morais, Juliana M Sciani, Vania G Branco, Rosemary V Bosch, Ana M Chudzinski-Tavassi

Get full text

Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity by Durvanei A. Maria, Sonia Elisabete A.L. Will, Rosemary V. Bosch, Jean G. Souza, Juliana M. Sciani, Mauricio B. Goldfeder, Giuliana G. Rondon, Ana M. Chudzinski-Tavassi

Get full text